Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TETREX

TETRACYCLINE PHOSPHATE COMPLEX

Standard Dose
EQ 500MG HYDROCHLORIDE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TETREX is listed in Drugs@FDA under application 061889 (ANDA).

Marketing status: Discontinued Active ingredient TETRACYCLINE PHOSPHATE COMPLEX Form and strength CAPSULE;ORAL - EQ 500MG HYDROCHLORIDE Sponsor BRISTOL Submission history Latest submission status date: 1974-12-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview TETREX is listed in Drugs@FDA under application 061889 (ANDA). Marketing status: Discontinued Active ingredient TETRACYCLINE PHOSPHATE COMPLEX Form and strength CAPSULE;ORAL - EQ 500MG HYDROCHLORIDE Sponsor BRISTOL Submission history Latest submission status date: 1974-12-05 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.